Ligand Pharmaceuticals | Despesas De Vendas E Administração



Selling And Administration Expenses Alterar Data
Amgen USD 1.88B 253M 2024-12
Arrowhead Research USD 30.2M 1.91M 2024-12
Baxter International USD 615M 16M 2024-12
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Glaxosmithkline GBP 2.7B 632M 2024-12
Insmed USD 142.51M 23.58M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
Ligand Pharmaceuticals USD 25.6M 1.13M 2024-12
MacroGenics USD 27.81M 13.71M 2024-12
Merck USD 2.85B 148M 2024-12
Pacira USD 79.61M 5.28M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Veracyte USD 50.72M 3.47M 2024-12



Ligand Pharmaceuticals Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.